A Phase I Study of KLA318-2 Nanocrystal Injection
NCT07171034 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2025-11-17
Summary
The purpose of this study is to evaluate the safety,tolerability and pharmacokinetics properties of KLA318-2 Nanocrystal Injection after a single intravenous injection in healthy participants.
Conditions
- Healthy Participants
Interventions
- DRUG
-
KLA318-2 Nanocrystal Injection
Intravenous injection, single dose
- DRUG
-
Celebrex Capsule
P.O., single dose
Sponsors & Collaborators
-
Hunan Kelun Pharmaceutical Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-09-01
- Primary Completion
- 2026-05-31
- Completion
- 2026-05-31
Countries
- China
Study Locations
More Related Trials
-
The Purpose of This Study is to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects.
NCT06994286 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-38877618 in Healthy Male Participants
NCT01964872 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics and Safety of Subcutaneous CSL324 in Healthy Japanese and White Subjects
NCT04570267 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Safety, and Tolerability Study of the Autoinjector and Pre-filled Syringe of SB4 in Healthy Male Subjects
NCT03193203 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability, and PK of Sibeprenlimab in Chinese Healthy Subject
NCT07105124 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects
NCT02834442 ·Status: COMPLETED ·Phase: PHASE1
-
Safety,Tolerability, and Pharmacokinetic of KPCXM18 for Injection
NCT04629287 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase 1 Study to Evaluate the Safety, Tolerability, PK and PD of SLN124 in Healthy Volunteers
NCT04559971 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Placebo-controlled Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Single- and Multiple-ascending Doses of ACT-1014-6470 in Healthy Subjects
NCT04608513 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ 61393215 in Healthy Participants
NCT03007693 ·Status: COMPLETED ·Phase: PHASE1
-
Single Ascending Dose Study of TD-0714 in Healthy Subjects
NCT02639078 ·Status: COMPLETED ·Phase: PHASE1
-
The PK/PD Study of A Single Subcutaneous Injection of SHR-1222 in Healthy Subjects
NCT03870100 ·Status: COMPLETED ·Phase: PHASE1
-
Study of SLN12140 in Healthy Adult Participants
NCT06945445 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability and PK of NPT520-34 in Healthy Subjects
NCT03954600 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Escalating Single Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ND-L02-s0201 Injection in Normal Healthy Subjects
NCT01858935 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety and Tolerability of JNJ-61178104 in Healthy Participants
NCT02758392 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, PK/PD, and Immunogenicity Study of SC ALXN2030 in Healthy Participants
NCT05501717 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-64264681 in Healthy Male and Female Participants
NCT03607513 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Tolerability of KJ103 in Healthy Adults
NCT05274659 ·Status: COMPLETED ·Phase: PHASE1
-
SB17170 Phase1 Trial in Healthy Volunteer
NCT05795192 ·Status: COMPLETED ·Phase: PHASE1
-
Study of CM313 in Healthy Subjects
NCT06285227 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of JNJ-61393215 in Healthy Japanese Male Participants
NCT04713930 ·Status: COMPLETED ·Phase: PHASE1
-
A Multiple Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SRK-001 in Healthy Participants
NCT05156034 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants
NCT02209506 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects
NCT02140125 ·Status: COMPLETED ·Phase: PHASE1